613 related articles for article (PubMed ID: 25444759)
1. Targeting the TGFβ pathway for cancer therapy.
Neuzillet C; Tijeras-Raballand A; Cohen R; Cros J; Faivre S; Raymond E; de Gramont A
Pharmacol Ther; 2015 Mar; 147():22-31. PubMed ID: 25444759
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of TGFβ signaling and its implications in anticancer treatments.
Calone I; Souchelnytskyi S
Exp Oncol; 2012; 34(1):9-16. PubMed ID: 22453142
[TBL] [Abstract][Full Text] [Related]
3. TGFβ Signaling in the Tumor Microenvironment.
Goulet CR; Pouliot F
Adv Exp Med Biol; 2021; 1270():89-105. PubMed ID: 33123995
[TBL] [Abstract][Full Text] [Related]
4. Targeting TGFbeta-mediated processes in cancer.
Romano MF
Curr Opin Drug Discov Devel; 2009 Mar; 12(2):253-63. PubMed ID: 19333871
[TBL] [Abstract][Full Text] [Related]
5. Role of TGFβ in regulation of the tumor microenvironment and drug delivery (review).
Papageorgis P; Stylianopoulos T
Int J Oncol; 2015 Mar; 46(3):933-43. PubMed ID: 25573346
[TBL] [Abstract][Full Text] [Related]
6. Targeting transforming growth factor-β signaling for enhanced cancer chemotherapy.
Chen J; Ding ZY; Li S; Liu S; Xiao C; Li Z; Zhang BX; Chen XP; Yang X
Theranostics; 2021; 11(3):1345-1363. PubMed ID: 33391538
[TBL] [Abstract][Full Text] [Related]
7. Large- and small-molecule inhibitors of transforming growth factor-beta signaling.
Akhurst RJ
Curr Opin Investig Drugs; 2006 Jun; 7(6):513-21. PubMed ID: 16784021
[TBL] [Abstract][Full Text] [Related]
8. Roles of TGFbeta in metastasis.
Padua D; Massagué J
Cell Res; 2009 Jan; 19(1):89-102. PubMed ID: 19050696
[TBL] [Abstract][Full Text] [Related]
9. Targeting TGFβ signal transduction for cancer therapy.
Liu S; Ren J; Ten Dijke P
Signal Transduct Target Ther; 2021 Jan; 6(1):8. PubMed ID: 33414388
[TBL] [Abstract][Full Text] [Related]
10. Role of TGFbeta signaling in skin carcinogenesis.
Wang XJ
Microsc Res Tech; 2001 Feb; 52(4):420-9. PubMed ID: 11170301
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta signaling and its targeted therapy in gastrointestinal cancers.
Gotovac JR; Fujihara KM; Phillips WA; Clemons NJ
Discov Med; 2018 Sep; 26(142):103-112. PubMed ID: 30399328
[TBL] [Abstract][Full Text] [Related]
12. Targeting breast cancer through its microenvironment: current status of preclinical and clinical research in finding relevant targets.
Nienhuis HH; Gaykema SB; Timmer-Bosscha H; Jalving M; Brouwers AH; Lub-de Hooge MN; van der Vegt B; Overmoyer B; de Vries EG; Schröder CP
Pharmacol Ther; 2015 Mar; 147():63-79. PubMed ID: 25444756
[TBL] [Abstract][Full Text] [Related]
13. Targeting TGFbeta signaling for cancer therapy.
Iyer S; Wang ZG; Akhtari M; Zhao W; Seth P
Cancer Biol Ther; 2005 Mar; 4(3):261-6. PubMed ID: 15846079
[TBL] [Abstract][Full Text] [Related]
14. Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer.
Bierie B; Moses HL
Nat Rev Cancer; 2006 Jul; 6(7):506-20. PubMed ID: 16794634
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta: a target for cancer therapy.
Kelly RJ; Morris JC
J Immunotoxicol; 2010 Mar; 7(1):15-26. PubMed ID: 19916703
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness.
Gaspar NJ; Li L; Kapoun AM; Medicherla S; Reddy M; Li G; O'Young G; Quon D; Henson M; Damm DL; Muiru GT; Murphy A; Higgins LS; Chakravarty S; Wong DH
Mol Pharmacol; 2007 Jul; 72(1):152-61. PubMed ID: 17400764
[TBL] [Abstract][Full Text] [Related]
17. TGFβ: A player on multiple fronts in the tumor microenvironment.
Caja F; Vannucci L
J Immunotoxicol; 2015; 12(3):300-7. PubMed ID: 25140864
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological inhibition of TGFβ as a strategy to augment the antitumor immune response.
Hanks BA; Morse MA
Curr Opin Investig Drugs; 2010 Dec; 11(12):1342-53. PubMed ID: 21154116
[TBL] [Abstract][Full Text] [Related]
19. TGF-β signaling pathway: Therapeutic targeting and potential for anti-cancer immunity.
Ali S; Rehman MU; Yatoo AM; Arafah A; Khan A; Rashid S; Majid S; Ali A; Ali MN
Eur J Pharmacol; 2023 May; 947():175678. PubMed ID: 36990262
[TBL] [Abstract][Full Text] [Related]
20. Escaping from the TGFbeta anti-proliferative control.
Seoane J
Carcinogenesis; 2006 Nov; 27(11):2148-56. PubMed ID: 16698802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
